Browse hierarchy: [Microbiology (MI)](/submissions/MI) → [Subpart D — Serological Reagents](/submissions/MI/subpart-d%E2%80%94serological-reagents) → [21 CFR 866.3332](/submissions/MI/subpart-d%E2%80%94serological-reagents/866.3332) → OMS — Novel Influenza A Virus, A/H5 Ns1 Protein

# OMS · Novel Influenza A Virus, A/H5 Ns1 Protein

_Microbiology · 21 CFR 866.3332 · Class 2_

**Canonical URL:** https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/OMS

## Overview

- **Product Code:** OMS
- **Device Name:** Novel Influenza A Virus, A/H5 Ns1 Protein
- **Regulation:** [21 CFR 866.3332](/submissions/MI/subpart-d%E2%80%94serological-reagents/866.3332)
- **Device Class:** 2
- **Review Panel:** [Microbiology](/submissions/MI)

## Identification

Reagents for detection of specific novel influenza A viruses are devices that are intended for use in a nucleic acid amplification test to directly detect specific virus RNA in human respiratory specimens or viral cultures. Detection of specific virus RNA aids in the diagnosis of influenza caused by specific novel influenza A viruses in patients with clinical risk of infection with these viruses, and also aids in the presumptive laboratory identification of specific novel influenza A viruses to provide epidemiological information on influenza. These reagents include primers, probes, and specific influenza A virus controls.

## Classification Rationale

Class II (special controls). The special controls are:

## Special Controls

The device is classified as Class II under regulation 21 CFR 866.3332 with special controls. The special control guidance document "Reagents for Detection of Specific Novel Influenza A viruses" will be available shortly.

*Classification.* Class II (special controls). The special controls are:(1) FDA's guidance document entitled “Class II Special Controls Guidance Document: Reagents for Detection of Specific Novel Influenza A Viruses.” See § 866.1(e) for information on obtaining this document.
(2) The distribution of these devices is limited to laboratories with experienced personnel who have training in standardized molecular testing procedures and expertise in viral diagnosis, and appropriate biosafety equipment and containment.

## Recent Cleared Devices (1 of 1)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [K083278](https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/OMS/K083278.md) | AVC A/H5N1 FLU TEST | Arbor Vita Corportation | Apr 8, 2009 | SESE |

## Top Applicants

- Arbor Vita Corportation — 1 clearance

---

**Source:** [https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/OMS](https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/OMS)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com